4 November 2015 - The U.S. FDA has approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance treatment of asthma in patients age 12 years and older.

For more details, go to: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm471031.htm